S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease (2014/9/17)|
|Robbins Arroyo LLP: Sanofi (SNY) Misled Shareholders According to a Recently Filed Class Action|
|Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-Component Strategic Collaboration (2014/12/2)|
|Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator (2014/11/18)|
|Unilife Signs 15-Year Commercial Supply Agreement for Wearable Injectors with Sanofi (2014/10/6)|
|Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection|
|Sanofi board ousts CEO Viehbacher after clash over strategy (2014/10/29)|
|SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Sanofi|
|Sanofi Expects $38 billion Sales Boost from New Drugs (2014/11/20)|
|Sanofi Gets FDA Approval for TB Drug Priftin (2014/12/2)|
Click above to view more mutual fund data and stats for san - Sanofi.